nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—TYMS—ovarian cancer	0.562	1	CbGaD
Leucovorin—ABCC3—Doxorubicin—ovarian cancer	0.0731	0.27	CbGbCtD
Leucovorin—ABCC2—Paclitaxel—ovarian cancer	0.0616	0.228	CbGbCtD
Leucovorin—ABCC2—Carboplatin—ovarian cancer	0.058	0.214	CbGbCtD
Leucovorin—ABCC2—Docetaxel—ovarian cancer	0.0446	0.165	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—ovarian cancer	0.0332	0.123	CbGbCtD
Leucovorin—Methotrexate—FOLR1—ovarian cancer	0.00204	0.353	CrCbGaD
Leucovorin—TYMS—Docetaxel—Paclitaxel—ovarian cancer	0.0017	0.472	CbGdCrCtD
Leucovorin—Raltitrexed—TYMS—ovarian cancer	0.00134	0.232	CrCbGaD
Leucovorin—ABCC3—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.00126	0.045	CbGpPWpGaD
Leucovorin—TYMS—uterine cervix—ovarian cancer	0.00118	0.0752	CbGeAlD
Leucovorin—TYMS—Nucleotide metabolism—NME2—ovarian cancer	0.00107	0.0381	CbGpPWpGaD
Leucovorin—TYMS—endometrium—ovarian cancer	0.00106	0.068	CbGeAlD
Leucovorin—Pralatrexate—TYMS—ovarian cancer	0.00102	0.176	CrCbGaD
Leucovorin—ABCC2—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000998	0.0357	CbGpPWpGaD
Leucovorin—TYMS—gonad—ovarian cancer	0.000986	0.063	CbGeAlD
Leucovorin—ABCC3—decidua—ovarian cancer	0.000919	0.0587	CbGeAlD
Leucovorin—TYMS—female reproductive system—ovarian cancer	0.000881	0.0563	CbGeAlD
Leucovorin—TYMS—Paclitaxel—Docetaxel—ovarian cancer	0.00085	0.236	CbGdCrCtD
Leucovorin—TYMS—G1/S-Specific Transcription—CCNE1—ovarian cancer	0.000832	0.0298	CbGpPWpGaD
Leucovorin—TYMS—bone marrow—ovarian cancer	0.000831	0.0532	CbGeAlD
Leucovorin—Pemetrexed—TYMS—ovarian cancer	0.000813	0.141	CrCbGaD
Leucovorin—TYMS—female gonad—ovarian cancer	0.000801	0.0512	CbGeAlD
Leucovorin—TYMS—vagina—ovarian cancer	0.000796	0.0509	CbGeAlD
Leucovorin—ABCC3—female reproductive system—ovarian cancer	0.000722	0.0462	CbGeAlD
Leucovorin—TYMS—testis—ovarian cancer	0.000711	0.0454	CbGeAlD
Leucovorin—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000689	0.0246	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.000688	0.0246	CbGpPWpGaD
Leucovorin—ABCC4—uterus—ovarian cancer	0.000663	0.0424	CbGeAlD
Leucovorin—ABCC3—female gonad—ovarian cancer	0.000657	0.042	CbGeAlD
Leucovorin—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000648	0.0232	CbGpPWpGaD
Leucovorin—ABCC4—female reproductive system—ovarian cancer	0.000596	0.0381	CbGeAlD
Leucovorin—TYMS—Vincristine—Vinorelbine—ovarian cancer	0.000584	0.162	CbGdCrCtD
Leucovorin—ABCC3—testis—ovarian cancer	0.000583	0.0373	CbGeAlD
Leucovorin—TYMS—E2F transcription factor network—RBL2—ovarian cancer	0.000581	0.0208	CbGpPWpGaD
Leucovorin—ABCC2—female reproductive system—ovarian cancer	0.000577	0.0369	CbGeAlD
Leucovorin—ABCC4—bone marrow—ovarian cancer	0.000563	0.036	CbGeAlD
Leucovorin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000546	0.0195	CbGpPWpGaD
Leucovorin—ABCC4—female gonad—ovarian cancer	0.000543	0.0347	CbGeAlD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—PPP2R1A—ovarian cancer	0.000527	0.0188	CbGpPWpGaD
Leucovorin—TYMS—lymph node—ovarian cancer	0.000515	0.0329	CbGeAlD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—CCNE1—ovarian cancer	0.00049	0.0175	CbGpPWpGaD
Leucovorin—ABCC4—testis—ovarian cancer	0.000481	0.0308	CbGeAlD
Leucovorin—TYMS—Vinblastine—Vinorelbine—ovarian cancer	0.00047	0.13	CbGdCrCtD
Leucovorin—ABCC2—testis—ovarian cancer	0.000466	0.0298	CbGeAlD
Leucovorin—ABCC2—Irinotecan Pathway—APC—ovarian cancer	0.00046	0.0164	CbGpPWpGaD
Leucovorin—Methotrexate—TYMS—ovarian cancer	0.000448	0.0777	CrCbGaD
Leucovorin—ABCC3—lymph node—ovarian cancer	0.000423	0.027	CbGeAlD
Leucovorin—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000415	0.0148	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000411	0.0147	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.000398	0.0142	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000396	0.0141	CbGpPWpGaD
Leucovorin—ABCC3—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.000378	0.0135	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.000374	0.0134	CbGpPWpGaD
Leucovorin—ABCC4—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.000355	0.0127	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—RBL2—ovarian cancer	0.000355	0.0127	CbGpPWpGaD
Leucovorin—ABCC4—lymph node—ovarian cancer	0.000349	0.0223	CbGeAlD
Leucovorin—ABCC2—lymph node—ovarian cancer	0.000338	0.0216	CbGeAlD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.000336	0.012	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.000335	0.012	CbGpPWpGaD
Leucovorin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000329	0.0118	CbGpPWpGaD
Leucovorin—Skin disorder—Topotecan—ovarian cancer	0.000326	0.00286	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000325	0.00286	CcSEcCtD
Leucovorin—Fatigue—Chlorambucil—ovarian cancer	0.000325	0.00285	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—TOP1—ovarian cancer	0.000322	0.0115	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Melphalan—ovarian cancer	0.000322	0.00283	CcSEcCtD
Leucovorin—Anorexia—Topotecan—ovarian cancer	0.00032	0.00281	CcSEcCtD
Leucovorin—Skin disorder—Melphalan—ovarian cancer	0.000319	0.0028	CcSEcCtD
Leucovorin—Malaise—Vinorelbine—ovarian cancer	0.000317	0.00279	CcSEcCtD
Leucovorin—Leukopenia—Vinorelbine—ovarian cancer	0.000315	0.00276	CcSEcCtD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000314	0.0112	CbGpPWpGaD
Leucovorin—Anorexia—Melphalan—ovarian cancer	0.000313	0.00275	CcSEcCtD
Leucovorin—Feeling abnormal—Chlorambucil—ovarian cancer	0.000311	0.00273	CcSEcCtD
Leucovorin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000308	0.00271	CcSEcCtD
Leucovorin—Abdominal pain upper—Docetaxel—ovarian cancer	0.000304	0.00267	CcSEcCtD
Leucovorin—ABCC2—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.0003	0.0107	CbGpPWpGaD
Leucovorin—Urticaria—Chlorambucil—ovarian cancer	0.000299	0.00263	CcSEcCtD
Leucovorin—Dyspnoea—Topotecan—ovarian cancer	0.000299	0.00263	CcSEcCtD
Leucovorin—Abdominal pain—Chlorambucil—ovarian cancer	0.000298	0.00262	CcSEcCtD
Leucovorin—Body temperature increased—Chlorambucil—ovarian cancer	0.000298	0.00262	CcSEcCtD
Leucovorin—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.000297	0.00261	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—BRCA1—ovarian cancer	0.000296	0.0106	CbGpPWpGaD
Leucovorin—Discomfort—Vinorelbine—ovarian cancer	0.000296	0.0026	CcSEcCtD
Leucovorin—Dyspepsia—Topotecan—ovarian cancer	0.000295	0.00259	CcSEcCtD
Leucovorin—Stomatitis—Paclitaxel—ovarian cancer	0.000295	0.00259	CcSEcCtD
Leucovorin—Dyspnoea—Melphalan—ovarian cancer	0.000293	0.00257	CcSEcCtD
Leucovorin—Decreased appetite—Topotecan—ovarian cancer	0.000292	0.00256	CcSEcCtD
Leucovorin—Neuropathy—Epirubicin—ovarian cancer	0.00029	0.00255	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00029	0.00254	CcSEcCtD
Leucovorin—Fatigue—Topotecan—ovarian cancer	0.000289	0.00254	CcSEcCtD
Leucovorin—Dyspepsia—Melphalan—ovarian cancer	0.000289	0.00254	CcSEcCtD
Leucovorin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000287	0.00252	CcSEcCtD
Leucovorin—Constipation—Topotecan—ovarian cancer	0.000287	0.00252	CcSEcCtD
Leucovorin—Decreased appetite—Melphalan—ovarian cancer	0.000286	0.00251	CcSEcCtD
Leucovorin—Infection—Vinorelbine—ovarian cancer	0.000285	0.0025	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000284	0.00249	CcSEcCtD
Leucovorin—Fatigue—Melphalan—ovarian cancer	0.000283	0.00249	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000281	0.0101	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000281	0.00247	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—SKP2—ovarian cancer	0.00028	0.01	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—SPARC—ovarian cancer	0.000279	0.00999	CbGpPWpGaD
Leucovorin—Skin disorder—Vinorelbine—ovarian cancer	0.000279	0.00245	CcSEcCtD
Leucovorin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000278	0.00244	CcSEcCtD
Leucovorin—Feeling abnormal—Topotecan—ovarian cancer	0.000276	0.00243	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—RSF1—ovarian cancer	0.000276	0.00988	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Topotecan—ovarian cancer	0.000274	0.00241	CcSEcCtD
Leucovorin—Anorexia—Vinorelbine—ovarian cancer	0.000274	0.0024	CcSEcCtD
Leucovorin—Asthenia—Chlorambucil—ovarian cancer	0.00027	0.00237	CcSEcCtD
Leucovorin—Neuropathy—Doxorubicin—ovarian cancer	0.000269	0.00236	CcSEcCtD
Leucovorin—Pruritus—Chlorambucil—ovarian cancer	0.000267	0.00234	CcSEcCtD
Leucovorin—Urticaria—Topotecan—ovarian cancer	0.000267	0.00234	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—ovarian cancer	0.000266	0.00952	CbGpPWpGaD
Leucovorin—Abdominal pain—Topotecan—ovarian cancer	0.000265	0.00233	CcSEcCtD
Leucovorin—Body temperature increased—Topotecan—ovarian cancer	0.000265	0.00233	CcSEcCtD
Leucovorin—Urticaria—Melphalan—ovarian cancer	0.000261	0.00229	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CCNE1—ovarian cancer	0.000259	0.00927	CbGpPWpGaD
Leucovorin—Diarrhoea—Chlorambucil—ovarian cancer	0.000258	0.00226	CcSEcCtD
Leucovorin—Dyspnoea—Vinorelbine—ovarian cancer	0.000256	0.00225	CcSEcCtD
Leucovorin—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000251	0.00221	CcSEcCtD
Leucovorin—Stomatitis—Docetaxel—ovarian cancer	0.00025	0.0022	CcSEcCtD
Leucovorin—Decreased appetite—Vinorelbine—ovarian cancer	0.000249	0.00219	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000248	0.00218	CcSEcCtD
Leucovorin—Fatigue—Vinorelbine—ovarian cancer	0.000247	0.00217	CcSEcCtD
Leucovorin—Hypersensitivity—Topotecan—ovarian cancer	0.000247	0.00217	CcSEcCtD
Leucovorin—Constipation—Vinorelbine—ovarian cancer	0.000245	0.00216	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—HNF1B—ovarian cancer	0.000244	0.00872	CbGpPWpGaD
Leucovorin—Chills—Paclitaxel—ovarian cancer	0.000244	0.00214	CcSEcCtD
Leucovorin—Renal failure acute—Epirubicin—ovarian cancer	0.000243	0.00214	CcSEcCtD
Leucovorin—Hypersensitivity—Melphalan—ovarian cancer	0.000242	0.00213	CcSEcCtD
Leucovorin—Asthenia—Topotecan—ovarian cancer	0.000241	0.00211	CcSEcCtD
Leucovorin—Alopecia—Paclitaxel—ovarian cancer	0.00024	0.00211	CcSEcCtD
Leucovorin—Vomiting—Chlorambucil—ovarian cancer	0.00024	0.0021	CcSEcCtD
Leucovorin—Pruritus—Topotecan—ovarian cancer	0.000237	0.00208	CcSEcCtD
Leucovorin—Erythema—Paclitaxel—ovarian cancer	0.000237	0.00208	CcSEcCtD
Leucovorin—Feeling abnormal—Vinorelbine—ovarian cancer	0.000237	0.00208	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—SKP2—ovarian cancer	0.000236	0.00845	CbGpPWpGaD
Leucovorin—Renal impairment—Epirubicin—ovarian cancer	0.000236	0.00207	CcSEcCtD
Leucovorin—Asthenia—Melphalan—ovarian cancer	0.000236	0.00207	CcSEcCtD
Leucovorin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000235	0.00206	CcSEcCtD
Leucovorin—Pruritus—Melphalan—ovarian cancer	0.000232	0.00204	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000232	0.00204	CcSEcCtD
Leucovorin—Dysgeusia—Paclitaxel—ovarian cancer	0.000232	0.00203	CcSEcCtD
Leucovorin—Diarrhoea—Topotecan—ovarian cancer	0.00023	0.00202	CcSEcCtD
Leucovorin—Lethargy—Epirubicin—ovarian cancer	0.000229	0.00201	CcSEcCtD
Leucovorin—Urticaria—Vinorelbine—ovarian cancer	0.000228	0.002	CcSEcCtD
Leucovorin—Body temperature increased—Vinorelbine—ovarian cancer	0.000227	0.00199	CcSEcCtD
Leucovorin—Abdominal pain—Vinorelbine—ovarian cancer	0.000227	0.00199	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.000225	0.00806	CbGpPWpGaD
Leucovorin—Renal failure acute—Doxorubicin—ovarian cancer	0.000225	0.00198	CcSEcCtD
Leucovorin—Diarrhoea—Melphalan—ovarian cancer	0.000225	0.00197	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—HDAC6—ovarian cancer	0.000224	0.00801	CbGpPWpGaD
Leucovorin—Nausea—Chlorambucil—ovarian cancer	0.000224	0.00197	CcSEcCtD
Leucovorin—Dizziness—Topotecan—ovarian cancer	0.000222	0.00195	CcSEcCtD
Leucovorin—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000219	0.00193	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—ovarian cancer	0.000218	0.00192	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000215	0.00189	CcSEcCtD
Leucovorin—Vomiting—Topotecan—ovarian cancer	0.000213	0.00187	CcSEcCtD
Leucovorin—Malaise—Paclitaxel—ovarian cancer	0.000213	0.00187	CcSEcCtD
Leucovorin—Syncope—Paclitaxel—ovarian cancer	0.000212	0.00186	CcSEcCtD
Leucovorin—Lethargy—Doxorubicin—ovarian cancer	0.000212	0.00186	CcSEcCtD
Leucovorin—Leukopenia—Paclitaxel—ovarian cancer	0.000212	0.00186	CcSEcCtD
Leucovorin—Rash—Topotecan—ovarian cancer	0.000212	0.00186	CcSEcCtD
Leucovorin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000211	0.00186	CcSEcCtD
Leucovorin—Dermatitis—Topotecan—ovarian cancer	0.000211	0.00186	CcSEcCtD
Leucovorin—Blood creatinine increased—Epirubicin—ovarian cancer	0.00021	0.00185	CcSEcCtD
Leucovorin—Vomiting—Melphalan—ovarian cancer	0.000209	0.00183	CcSEcCtD
Leucovorin—Loss of consciousness—Paclitaxel—ovarian cancer	0.000208	0.00183	CcSEcCtD
Leucovorin—Rash—Melphalan—ovarian cancer	0.000207	0.00182	CcSEcCtD
Leucovorin—Dermatitis—Melphalan—ovarian cancer	0.000207	0.00182	CcSEcCtD
Leucovorin—Chills—Docetaxel—ovarian cancer	0.000207	0.00182	CcSEcCtD
Leucovorin—Asthenia—Vinorelbine—ovarian cancer	0.000206	0.00181	CcSEcCtD
Leucovorin—Abdominal pain upper—Epirubicin—ovarian cancer	0.000205	0.0018	CcSEcCtD
Leucovorin—Convulsion—Paclitaxel—ovarian cancer	0.000205	0.0018	CcSEcCtD
Leucovorin—Alopecia—Docetaxel—ovarian cancer	0.000204	0.00179	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—SOD1—ovarian cancer	0.000203	0.00726	CbGpPWpGaD
Leucovorin—Pruritus—Vinorelbine—ovarian cancer	0.000203	0.00178	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—PPP2R1A—ovarian cancer	0.000203	0.00725	CbGpPWpGaD
Leucovorin—Erythema—Docetaxel—ovarian cancer	0.0002	0.00176	CcSEcCtD
Leucovorin—Nausea—Topotecan—ovarian cancer	0.000199	0.00175	CcSEcCtD
Leucovorin—Discomfort—Paclitaxel—ovarian cancer	0.000199	0.00175	CcSEcCtD
Leucovorin—Diarrhoea—Vinorelbine—ovarian cancer	0.000196	0.00172	CcSEcCtD
Leucovorin—Dysgeusia—Docetaxel—ovarian cancer	0.000196	0.00172	CcSEcCtD
Leucovorin—Nausea—Melphalan—ovarian cancer	0.000195	0.00171	CcSEcCtD
Leucovorin—Confusional state—Paclitaxel—ovarian cancer	0.000195	0.00171	CcSEcCtD
Leucovorin—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000195	0.00171	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—ovarian cancer	0.000193	0.00692	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000193	0.0017	CcSEcCtD
Leucovorin—Infection—Paclitaxel—ovarian cancer	0.000192	0.00168	CcSEcCtD
Leucovorin—Shock—Paclitaxel—ovarian cancer	0.00019	0.00167	CcSEcCtD
Leucovorin—Dizziness—Vinorelbine—ovarian cancer	0.00019	0.00167	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00019	0.00167	CcSEcCtD
Leucovorin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000189	0.00166	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—CCNE1—ovarian cancer	0.000188	0.00673	CbGpPWpGaD
Leucovorin—Skin disorder—Paclitaxel—ovarian cancer	0.000188	0.00165	CcSEcCtD
Leucovorin—Anorexia—Paclitaxel—ovarian cancer	0.000184	0.00162	CcSEcCtD
Leucovorin—Vomiting—Vinorelbine—ovarian cancer	0.000182	0.0016	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CCND2—ovarian cancer	0.000181	0.00647	CbGpPWpGaD
Leucovorin—Rash—Vinorelbine—ovarian cancer	0.000181	0.00159	CcSEcCtD
Leucovorin—Dermatitis—Vinorelbine—ovarian cancer	0.000181	0.00159	CcSEcCtD
Leucovorin—Syncope—Docetaxel—ovarian cancer	0.00018	0.00158	CcSEcCtD
Leucovorin—Leukopenia—Docetaxel—ovarian cancer	0.000179	0.00158	CcSEcCtD
Leucovorin—Loss of consciousness—Docetaxel—ovarian cancer	0.000176	0.00155	CcSEcCtD
Leucovorin—Convulsion—Docetaxel—ovarian cancer	0.000174	0.00153	CcSEcCtD
Leucovorin—Dyspnoea—Paclitaxel—ovarian cancer	0.000172	0.00151	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	0.000171	0.00611	CbGpPWpGaD
Leucovorin—Nausea—Vinorelbine—ovarian cancer	0.00017	0.0015	CcSEcCtD
Leucovorin—Dyspepsia—Paclitaxel—ovarian cancer	0.00017	0.00149	CcSEcCtD
Leucovorin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00017	0.00149	CcSEcCtD
Leucovorin—Stomatitis—Epirubicin—ovarian cancer	0.000169	0.00148	CcSEcCtD
Leucovorin—Decreased appetite—Paclitaxel—ovarian cancer	0.000168	0.00147	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000167	0.00146	CcSEcCtD
Leucovorin—Fatigue—Paclitaxel—ovarian cancer	0.000166	0.00146	CcSEcCtD
Leucovorin—Constipation—Paclitaxel—ovarian cancer	0.000165	0.00145	CcSEcCtD
Leucovorin—Confusional state—Docetaxel—ovarian cancer	0.000165	0.00145	CcSEcCtD
Leucovorin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000164	0.00144	CcSEcCtD
Leucovorin—Infection—Docetaxel—ovarian cancer	0.000163	0.00143	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—SLC5A5—ovarian cancer	0.000162	0.00578	CbGpPWpGaD
Leucovorin—Shock—Docetaxel—ovarian cancer	0.000161	0.00141	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.00016	0.00573	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Docetaxel—ovarian cancer	0.00016	0.00141	CcSEcCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000159	0.0057	CbGpPWpGaD
Leucovorin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000159	0.0014	CcSEcCtD
Leucovorin—Skin disorder—Docetaxel—ovarian cancer	0.000159	0.0014	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	0.000159	0.00567	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000158	0.00139	CcSEcCtD
Leucovorin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000157	0.00138	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—SLC2A1—ovarian cancer	0.000156	0.00558	CbGpPWpGaD
Leucovorin—Stomatitis—Doxorubicin—ovarian cancer	0.000156	0.00137	CcSEcCtD
Leucovorin—Anorexia—Docetaxel—ovarian cancer	0.000156	0.00137	CcSEcCtD
Leucovorin—Urticaria—Paclitaxel—ovarian cancer	0.000153	0.00135	CcSEcCtD
Leucovorin—Body temperature increased—Paclitaxel—ovarian cancer	0.000153	0.00134	CcSEcCtD
Leucovorin—Abdominal pain—Paclitaxel—ovarian cancer	0.000153	0.00134	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—SLC5A5—ovarian cancer	0.000152	0.00544	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—SLC2A1—ovarian cancer	0.000147	0.00525	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000146	0.00523	CbGpPWpGaD
Leucovorin—Dyspnoea—Docetaxel—ovarian cancer	0.000146	0.00128	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—RAD51C—ovarian cancer	0.000145	0.00519	CbGpPWpGaD
Leucovorin—Dyspepsia—Docetaxel—ovarian cancer	0.000144	0.00127	CcSEcCtD
Leucovorin—Decreased appetite—Docetaxel—ovarian cancer	0.000142	0.00125	CcSEcCtD
Leucovorin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000142	0.00125	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.000142	0.00507	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000141	0.00124	CcSEcCtD
Leucovorin—Fatigue—Docetaxel—ovarian cancer	0.000141	0.00124	CcSEcCtD
Leucovorin—Constipation—Docetaxel—ovarian cancer	0.00014	0.00123	CcSEcCtD
Leucovorin—Chills—Epirubicin—ovarian cancer	0.000139	0.00122	CcSEcCtD
Leucovorin—Asthenia—Paclitaxel—ovarian cancer	0.000139	0.00122	CcSEcCtD
Leucovorin—Alopecia—Epirubicin—ovarian cancer	0.000137	0.00121	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000137	0.00491	CbGpPWpGaD
Leucovorin—Pruritus—Paclitaxel—ovarian cancer	0.000137	0.0012	CcSEcCtD
Leucovorin—Erythema—Epirubicin—ovarian cancer	0.000135	0.00119	CcSEcCtD
Leucovorin—Feeling abnormal—Docetaxel—ovarian cancer	0.000135	0.00118	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CDKN1B—ovarian cancer	0.000134	0.00481	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000134	0.00118	CcSEcCtD
Leucovorin—Dysgeusia—Epirubicin—ovarian cancer	0.000132	0.00116	CcSEcCtD
Leucovorin—Diarrhoea—Paclitaxel—ovarian cancer	0.000132	0.00116	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000132	0.00472	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—RBL2—ovarian cancer	0.00013	0.00466	CbGpPWpGaD
Leucovorin—Body temperature increased—Docetaxel—ovarian cancer	0.000129	0.00114	CcSEcCtD
Leucovorin—Abdominal pain—Docetaxel—ovarian cancer	0.000129	0.00114	CcSEcCtD
Leucovorin—Chills—Doxorubicin—ovarian cancer	0.000129	0.00113	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—SLC5A5—ovarian cancer	0.000128	0.00458	CbGpPWpGaD
Leucovorin—Dizziness—Paclitaxel—ovarian cancer	0.000128	0.00112	CcSEcCtD
Leucovorin—Alopecia—Doxorubicin—ovarian cancer	0.000127	0.00112	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—PPP1CC—ovarian cancer	0.000127	0.00453	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000125	0.0011	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—ovarian cancer	0.000125	0.0011	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000124	0.00444	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000124	0.00444	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	0.000124	0.00443	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—SLC2A1—ovarian cancer	0.000124	0.00443	CbGpPWpGaD
Leucovorin—Vomiting—Paclitaxel—ovarian cancer	0.000123	0.00108	CcSEcCtD
Leucovorin—Dysgeusia—Doxorubicin—ovarian cancer	0.000123	0.00108	CcSEcCtD
Leucovorin—Malaise—Epirubicin—ovarian cancer	0.000122	0.00107	CcSEcCtD
Leucovorin—Rash—Paclitaxel—ovarian cancer	0.000122	0.00107	CcSEcCtD
Leucovorin—Dermatitis—Paclitaxel—ovarian cancer	0.000122	0.00107	CcSEcCtD
Leucovorin—Syncope—Epirubicin—ovarian cancer	0.000121	0.00107	CcSEcCtD
Leucovorin—Leukopenia—Epirubicin—ovarian cancer	0.000121	0.00106	CcSEcCtD
Leucovorin—Hypersensitivity—Docetaxel—ovarian cancer	0.000121	0.00106	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.00012	0.0043	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.00012	0.0043	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—RAD51C—ovarian cancer	0.00012	0.00428	CbGpPWpGaD
Leucovorin—Loss of consciousness—Epirubicin—ovarian cancer	0.000119	0.00104	CcSEcCtD
Leucovorin—Asthenia—Docetaxel—ovarian cancer	0.000117	0.00103	CcSEcCtD
Leucovorin—Convulsion—Epirubicin—ovarian cancer	0.000117	0.00103	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000117	0.00418	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—RBL2—ovarian cancer	0.000116	0.00416	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000116	0.00102	CcSEcCtD
Leucovorin—Pruritus—Docetaxel—ovarian cancer	0.000116	0.00102	CcSEcCtD
Leucovorin—Nausea—Paclitaxel—ovarian cancer	0.000115	0.00101	CcSEcCtD
Leucovorin—Discomfort—Epirubicin—ovarian cancer	0.000114	0.000999	CcSEcCtD
Leucovorin—Methotrexate—ABCB1—ovarian cancer	0.000114	0.0197	CrCbGaD
Leucovorin—Malaise—Doxorubicin—ovarian cancer	0.000113	0.000991	CcSEcCtD
Leucovorin—Syncope—Doxorubicin—ovarian cancer	0.000112	0.000986	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—ovarian cancer	0.000112	0.000984	CcSEcCtD
Leucovorin—Diarrhoea—Docetaxel—ovarian cancer	0.000112	0.000983	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000111	0.00399	CbGpPWpGaD
Leucovorin—Confusional state—Epirubicin—ovarian cancer	0.000111	0.000977	CcSEcCtD
Leucovorin—Anaphylactic shock—Epirubicin—ovarian cancer	0.00011	0.000969	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—ovarian cancer	0.00011	0.000966	CcSEcCtD
Leucovorin—Infection—Epirubicin—ovarian cancer	0.00011	0.000963	CcSEcCtD
Leucovorin—Shock—Epirubicin—ovarian cancer	0.000109	0.000954	CcSEcCtD
Leucovorin—Convulsion—Doxorubicin—ovarian cancer	0.000108	0.000952	CcSEcCtD
Leucovorin—Dizziness—Docetaxel—ovarian cancer	0.000108	0.00095	CcSEcCtD
Leucovorin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000108	0.000949	CcSEcCtD
Leucovorin—Skin disorder—Epirubicin—ovarian cancer	0.000107	0.000942	CcSEcCtD
Leucovorin—Discomfort—Doxorubicin—ovarian cancer	0.000105	0.000924	CcSEcCtD
Leucovorin—Anorexia—Epirubicin—ovarian cancer	0.000105	0.000924	CcSEcCtD
Leucovorin—Vomiting—Docetaxel—ovarian cancer	0.000104	0.000914	CcSEcCtD
Leucovorin—Rash—Docetaxel—ovarian cancer	0.000103	0.000906	CcSEcCtD
Leucovorin—Dermatitis—Docetaxel—ovarian cancer	0.000103	0.000905	CcSEcCtD
Leucovorin—Confusional state—Doxorubicin—ovarian cancer	0.000103	0.000904	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—MYC—ovarian cancer	0.000103	0.00368	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000102	0.00366	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000102	0.000897	CcSEcCtD
Leucovorin—Infection—Doxorubicin—ovarian cancer	0.000101	0.000891	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000101	0.00362	CbGpPWpGaD
Leucovorin—Shock—Doxorubicin—ovarian cancer	0.0001	0.000882	CcSEcCtD
Leucovorin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.0001	0.000878	CcSEcCtD
Leucovorin—Skin disorder—Doxorubicin—ovarian cancer	9.92e-05	0.000871	CcSEcCtD
Leucovorin—Dyspnoea—Epirubicin—ovarian cancer	9.84e-05	0.000864	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	9.82e-05	0.00351	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—CDKN1B—ovarian cancer	9.76e-05	0.00349	CbGpPWpGaD
Leucovorin—Anorexia—Doxorubicin—ovarian cancer	9.73e-05	0.000855	CcSEcCtD
Leucovorin—Nausea—Docetaxel—ovarian cancer	9.72e-05	0.000854	CcSEcCtD
Leucovorin—Dyspepsia—Epirubicin—ovarian cancer	9.72e-05	0.000853	CcSEcCtD
Leucovorin—TYMS—Metabolism—NME2—ovarian cancer	9.68e-05	0.00346	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—AQP3—ovarian cancer	9.63e-05	0.00344	CbGpPWpGaD
Leucovorin—Decreased appetite—Epirubicin—ovarian cancer	9.59e-05	0.000843	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Epirubicin—ovarian cancer	9.53e-05	0.000837	CcSEcCtD
Leucovorin—Fatigue—Epirubicin—ovarian cancer	9.52e-05	0.000836	CcSEcCtD
Leucovorin—Constipation—Epirubicin—ovarian cancer	9.44e-05	0.000829	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	9.23e-05	0.0033	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	9.16e-05	0.00328	CbGpPWpGaD
Leucovorin—Dyspnoea—Doxorubicin—ovarian cancer	9.1e-05	0.0008	CcSEcCtD
Leucovorin—Feeling abnormal—Epirubicin—ovarian cancer	9.09e-05	0.000799	CcSEcCtD
Leucovorin—Gastrointestinal pain—Epirubicin—ovarian cancer	9.03e-05	0.000793	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	9.01e-05	0.00322	CbGpPWpGaD
Leucovorin—Dyspepsia—Doxorubicin—ovarian cancer	8.99e-05	0.00079	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	8.94e-05	0.0032	CbGpPWpGaD
Leucovorin—Decreased appetite—Doxorubicin—ovarian cancer	8.88e-05	0.00078	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.82e-05	0.000774	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—ovarian cancer	8.8e-05	0.000773	CcSEcCtD
Leucovorin—Urticaria—Epirubicin—ovarian cancer	8.77e-05	0.00077	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—ovarian cancer	8.73e-05	0.000767	CcSEcCtD
Leucovorin—Abdominal pain—Epirubicin—ovarian cancer	8.72e-05	0.000766	CcSEcCtD
Leucovorin—Body temperature increased—Epirubicin—ovarian cancer	8.72e-05	0.000766	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—SKP2—ovarian cancer	8.67e-05	0.0031	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	8.66e-05	0.0031	CbGpPWpGaD
Leucovorin—Feeling abnormal—Doxorubicin—ovarian cancer	8.42e-05	0.000739	CcSEcCtD
Leucovorin—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.35e-05	0.000733	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	8.22e-05	0.00294	CbGpPWpGaD
Leucovorin—Hypersensitivity—Epirubicin—ovarian cancer	8.13e-05	0.000714	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—AQP3—ovarian cancer	8.12e-05	0.0029	CbGpPWpGaD
Leucovorin—Urticaria—Doxorubicin—ovarian cancer	8.11e-05	0.000713	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—VEGFA—ovarian cancer	8.09e-05	0.00289	CbGpPWpGaD
Leucovorin—Abdominal pain—Doxorubicin—ovarian cancer	8.07e-05	0.000709	CcSEcCtD
Leucovorin—Body temperature increased—Doxorubicin—ovarian cancer	8.07e-05	0.000709	CcSEcCtD
Leucovorin—ABCC3—Metabolism—NME2—ovarian cancer	8.01e-05	0.00286	CbGpPWpGaD
Leucovorin—Asthenia—Epirubicin—ovarian cancer	7.92e-05	0.000695	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CCND1—ovarian cancer	7.84e-05	0.0028	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MLH1—ovarian cancer	7.84e-05	0.0028	CbGpPWpGaD
Leucovorin—Pruritus—Epirubicin—ovarian cancer	7.81e-05	0.000686	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	7.79e-05	0.00278	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.76e-05	0.00278	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—SKP2—ovarian cancer	7.75e-05	0.00277	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	7.71e-05	0.00275	CbGpPWpGaD
Leucovorin—Diarrhoea—Epirubicin—ovarian cancer	7.55e-05	0.000663	CcSEcCtD
Leucovorin—Hypersensitivity—Doxorubicin—ovarian cancer	7.52e-05	0.000661	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—MYC—ovarian cancer	7.47e-05	0.00267	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	7.34e-05	0.00263	CbGpPWpGaD
Leucovorin—Asthenia—Doxorubicin—ovarian cancer	7.33e-05	0.000644	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.3e-05	0.00261	CbGpPWpGaD
Leucovorin—Dizziness—Epirubicin—ovarian cancer	7.3e-05	0.000641	CcSEcCtD
Leucovorin—Pruritus—Doxorubicin—ovarian cancer	7.23e-05	0.000635	CcSEcCtD
Leucovorin—Vomiting—Epirubicin—ovarian cancer	7.02e-05	0.000616	CcSEcCtD
Leucovorin—Diarrhoea—Doxorubicin—ovarian cancer	6.99e-05	0.000614	CcSEcCtD
Leucovorin—Rash—Epirubicin—ovarian cancer	6.96e-05	0.000611	CcSEcCtD
Leucovorin—Dermatitis—Epirubicin—ovarian cancer	6.95e-05	0.000611	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.79e-05	0.00243	CbGpPWpGaD
Leucovorin—Dizziness—Doxorubicin—ovarian cancer	6.75e-05	0.000593	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	6.73e-05	0.0024	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCND2—ovarian cancer	6.64e-05	0.00237	CbGpPWpGaD
Leucovorin—Nausea—Epirubicin—ovarian cancer	6.56e-05	0.000576	CcSEcCtD
Leucovorin—Vomiting—Doxorubicin—ovarian cancer	6.49e-05	0.00057	CcSEcCtD
Leucovorin—Rash—Doxorubicin—ovarian cancer	6.44e-05	0.000566	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—ovarian cancer	6.43e-05	0.000565	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—SPARC—ovarian cancer	6.39e-05	0.00228	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CHEK2—ovarian cancer	6.34e-05	0.00227	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—ovarian cancer	6.29e-05	0.00225	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	6.27e-05	0.00224	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYTB—ovarian cancer	6.23e-05	0.00223	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	6.23e-05	0.00223	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	6.15e-05	0.0022	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	6.11e-05	0.00218	CbGpPWpGaD
Leucovorin—Nausea—Doxorubicin—ovarian cancer	6.07e-05	0.000533	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	6e-05	0.00214	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	5.94e-05	0.00212	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—CTNNB1—ovarian cancer	5.94e-05	0.00212	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BRCA1—ovarian cancer	5.94e-05	0.00212	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCND2—ovarian cancer	5.94e-05	0.00212	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	5.88e-05	0.0021	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCNE1—ovarian cancer	5.82e-05	0.00208	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	5.74e-05	0.00205	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—PPP2R1A—ovarian cancer	5.6e-05	0.002	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.54e-05	0.00198	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PTEN—ovarian cancer	5.51e-05	0.00197	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PPP1CC—ovarian cancer	5.45e-05	0.00195	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—BRIP1—ovarian cancer	5.45e-05	0.00195	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BRCA2—ovarian cancer	5.37e-05	0.00192	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	5.27e-05	0.00189	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCNE1—ovarian cancer	5.2e-05	0.00186	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	5.18e-05	0.00185	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.18e-05	0.00185	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYTB—ovarian cancer	5.16e-05	0.00184	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—BIRC5—ovarian cancer	5.14e-05	0.00184	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.04e-05	0.0018	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5e-05	0.00179	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	4.9e-05	0.00175	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.87e-05	0.00174	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—ovarian cancer	4.81e-05	0.00172	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	4.77e-05	0.0017	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.7e-05	0.00168	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	4.66e-05	0.00167	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	4.66e-05	0.00167	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—SOD1—ovarian cancer	4.64e-05	0.00166	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PPP2R1A—ovarian cancer	4.62e-05	0.00165	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	4.6e-05	0.00164	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BIRC5—ovarian cancer	4.59e-05	0.00164	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PPP1CC—ovarian cancer	4.51e-05	0.00161	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—BRIP1—ovarian cancer	4.51e-05	0.00161	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TERT—ovarian cancer	4.45e-05	0.00159	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	4.4e-05	0.00157	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IL2—ovarian cancer	4.22e-05	0.00151	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.11e-05	0.00147	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	4.05e-05	0.00145	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.97e-05	0.00142	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.95e-05	0.00141	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.91e-05	0.0014	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—ovarian cancer	3.76e-05	0.00134	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.71e-05	0.00133	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—YAP1—ovarian cancer	3.66e-05	0.00131	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	3.59e-05	0.00128	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—IL6—ovarian cancer	3.44e-05	0.00123	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—CAV1—ovarian cancer	3.39e-05	0.00121	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	3.39e-05	0.00121	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.31e-05	0.00118	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.29e-05	0.00118	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	3.23e-05	0.00115	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.13e-05	0.00112	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CG—ovarian cancer	3.09e-05	0.00111	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—YAP1—ovarian cancer	3.03e-05	0.00108	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	3.02e-05	0.00108	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.99e-05	0.00107	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—FASN—ovarian cancer	2.98e-05	0.00107	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC5A5—ovarian cancer	2.93e-05	0.00105	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCND1—ovarian cancer	2.88e-05	0.00103	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC2A1—ovarian cancer	2.83e-05	0.00101	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	2.8e-05	0.001	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CD—ovarian cancer	2.72e-05	0.000972	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP1B1—ovarian cancer	2.71e-05	0.00097	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN1B—ovarian cancer	2.7e-05	0.000964	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.63e-05	0.000941	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCND1—ovarian cancer	2.57e-05	0.00092	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—FASN—ovarian cancer	2.47e-05	0.000882	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC5A5—ovarian cancer	2.43e-05	0.000867	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PPP2R1A—ovarian cancer	2.41e-05	0.00086	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.37e-05	0.000848	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CB—ovarian cancer	2.37e-05	0.000847	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC2A1—ovarian cancer	2.34e-05	0.000838	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—ovarian cancer	2.31e-05	0.000825	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.29e-05	0.00082	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	2.29e-05	0.000818	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.26e-05	0.000807	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP1B1—ovarian cancer	2.25e-05	0.000803	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ABCB1—ovarian cancer	2.23e-05	0.000799	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IL2—ovarian cancer	2.18e-05	0.000778	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MAPK3—ovarian cancer	2.12e-05	0.000758	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—ovarian cancer	2.06e-05	0.000738	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MAPK1—ovarian cancer	2.02e-05	0.000722	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PPP2R1A—ovarian cancer	1.99e-05	0.000712	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.98e-05	0.000709	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ABCB1—ovarian cancer	1.85e-05	0.000661	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—VEGFA—ovarian cancer	1.85e-05	0.000661	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—NRAS—ovarian cancer	1.83e-05	0.000653	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TYMS—ovarian cancer	1.82e-05	0.000649	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CAV1—ovarian cancer	1.77e-05	0.000632	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—MAPK3—ovarian cancer	1.75e-05	0.000625	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—ovarian cancer	1.69e-05	0.000606	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—MAPK1—ovarian cancer	1.66e-05	0.000595	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CG—ovarian cancer	1.61e-05	0.000576	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KRAS—ovarian cancer	1.57e-05	0.000562	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CAV1—ovarian cancer	1.46e-05	0.000523	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CA—ovarian cancer	1.44e-05	0.000516	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CD—ovarian cancer	1.42e-05	0.000506	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.4e-05	0.0005	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—ovarian cancer	1.4e-05	0.0005	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HRAS—ovarian cancer	1.34e-05	0.000478	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CG—ovarian cancer	1.33e-05	0.000477	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CB—ovarian cancer	1.23e-05	0.000441	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—AKT1—ovarian cancer	1.18e-05	0.000422	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CD—ovarian cancer	1.17e-05	0.000419	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTEN—ovarian cancer	1.07e-05	0.000381	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CB—ovarian cancer	1.02e-05	0.000365	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTEN—ovarian cancer	8.83e-06	0.000316	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CA—ovarian cancer	7.53e-06	0.000269	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CA—ovarian cancer	6.23e-06	0.000223	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKT1—ovarian cancer	6.15e-06	0.00022	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKT1—ovarian cancer	5.09e-06	0.000182	CbGpPWpGaD
